Darine Ghanem: Advancing Health Equity in Care at the LATAM Meeting
Darine Ghanem, Commercialisation Excellence Lead for Non-Malignant Hemathology at Roche, shared on LinkedIn:
” ‘Geographic location should not be a stronger determinant of health outcomes than genetic inheritance.’
For people living with hemophilia, where they are born or live can have a greater impact on their health outcomes than the condition itself.
This week, I had the privilege of attending the LATAM Hemophilia Meeting and engaging with healthcare professionals, patient advocates, and policymakers from across Latin America.
Despite our different healthcare systems and realities, we shared a common goal: ensuring that every person living with hemophilia can benefit from innovative care and achieve the best possible clinical and human outcomes.
One message stood out: innovation is redefining what is possible in hemophilia care.
Beyond reducing bleeds and improving clinical outcomes, it is enabling greater independence, participation, and quality of life for patients and their families.
But innovation only fulfills its promise when it reaches those who need it most.
Access to innovative care should not depend on geography, infrastructure, or policy barriers. It is not a privilege.
It is not a luxury.It is a human right.
The discussions reinforced the importance of collaboration across public and private sectors to close access gaps and ensure that scientific progress translates into meaningful improvements in patients’ lives.
I am proud to work for Roche, partnering with healthcare systems, healthcare professionals, patient communities, and policymakers to advance health equity and expand access to innovative hemophilia care.
Because the future of hemophilia care should be defined by innovation, equity, and better outcomes and not by inequality.
This vision is now reflected at the highest level of global health policy.
On 21 May 2026, the 79th World Health Assembly adopted the historic Resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding
Disorders, sending a clear message: health equity for people with hemophilia is a global priority and a shared responsibility.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 13:44Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
-
Jun 1, 2026, 13:39Abdul Mannan: The Moral Injury of Practising Haemato-Oncology in a Resource-Limited Setting
-
Jun 1, 2026, 13:34Filza Aslam: What Does a Patient Journey Partner Actually Do in Bleeding Disorders?
-
Jun 1, 2026, 13:23Skye Collado: Miller-Keystone Blood Center Expands Community Impact Through the Addition of New Bloodmobiles
-
Jun 1, 2026, 12:37Rutuja Mahadik: Anemia is More Than Just Feeling Tired
-
Jun 1, 2026, 12:36Ankur Jindal: Large-Vessel Inflammation and Immune Dysregulation in Wiskott–Aldrich Syndrome
-
Jun 1, 2026, 12:35Shadi Almassri: Conditions That Can Cause False High or False Low HbA1c Results
-
Jun 1, 2026, 12:22Ed Davidson: Clot Removing Technology That Can Change the Game
-
Jun 1, 2026, 12:17Tagreed Alkaltham: Building Blood Systems for Both Efficiency and Resilience